<DOC>
	<DOCNO>NCT01780883</DOCNO>
	<brief_summary>Melatonin neurohormone produce serotonin promotes sleep . The alteration central peripheral serotonin neurobiology circadian sleep-wake rhythm observe autistic disorder suggest abnormality melatonin secretion . Several study report decrease melatonin secretion individual autism . Furthermore , nocturnal excretion 6-Sulphatoxymelatonin ( predominant melatonin metabolite ) significantly negatively correlated severity autistic impairment verbal communication play . Melatonin could therefore therapeutic effect sleep problem may play role pathophysiology autistic disorder . These data highlight possible therapeutic interest oral administration melatonin patient autistic disorder . Thus , objective clinical trial study relation melatonin dose administer effect severity autistic impairment especially verbal communication play .</brief_summary>
	<brief_title>Melatonin Dose-effect Relation Childhood Autism</brief_title>
	<detailed_description>The hormone melatonin interest autism due theoretical consideration report alter melatonin production individual autism . Melatonin produce pineal gland help regulate human circadian rhythm include sleep-wake , consider best measure circadian rhythm . Several study reveal plasmatic urinary nocturnal level melatonin significantly low individual autism ( particular , prepubertal child ) compare typically develop individual . In addition , reduction nocturnal melatonin significantly associate severity communication social interaction impairment , especially verbal communication play . Finally , diurnal excretion melatonin also find decreased individual autistic disorder . Given result , administration melatonin could serve , least prepubertal child wih autism , normalize physiological , developmental behavioral process influence pineal hormone . A randomized clinical trial therefore necessary establish potential therapeutic efficacy melatonin autistic disorder specify dose-effect relation . This first clinical trial study melatonin dose-effect autism .</detailed_description>
	<mesh_term>Autistic Disorder</mesh_term>
	<mesh_term>Melatonin</mesh_term>
	<criteria>Prepubertal male autism 6 8 year old , accord diagnostic criterion autistic disorder WHO ( CIM10 ) , American ( DSMIVTR ) French ( CFTMEA ) classification . Verbal language level require ADOS ( Module 1 ) ( i.e. , verbal language define ADIR ( autism diagnostic interviewrevised ) scale ) . Written inform consent parent legal representative . Noninclusion Criteria : Treatment benzodiazepine . Treatment anticonvulsant drug . Treatment serotoninergic product . Hypersensitivity reaction active substance one excipients product . Patient hereditary galactose intolerance , Lapp lactase deficiency malabsorption syndrome glucose galactose . Children able swallow tablet .</criteria>
	<gender>Male</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>8 Years</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>melatonin</keyword>
	<keyword>childhood autism</keyword>
	<keyword>6-Sulphatoxymelatonin</keyword>
	<keyword>autistic disorder</keyword>
	<keyword>dose-effect relation</keyword>
</DOC>